| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/02/1999 | US5866124 Antiidiotypic antibodies for high molecular weight-melanoma associated antigen |
| 02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
| 02/02/1999 | US5866122 Using prothrombinase |
| 02/02/1999 | US5866121 Method for targeting degradation of intracellular proteins |
| 02/02/1999 | US5866120 Therapy for vision defects |
| 02/02/1999 | US5866119 Hybridization; complexing |
| 02/02/1999 | US5866115 Process for preparing dendritic cells, cells thus produced and containers for carrying out this process |
| 02/02/1999 | US5866114 Macrophage colony stimulating factor |
| 02/02/1999 | US5866097 Technetium-99m labeled peptides for imaging |
| 02/02/1999 | US5865784 Method of hemodilution facilitated by monitoring oxygenation status |
| 02/02/1999 | US5865744 Method and system for delivering therapeutic agents |
| 02/02/1999 | CA2182200C Formulations for factor ix |
| 02/02/1999 | CA2053275C Fibroblast growth factor conjugates |
| 02/02/1999 | CA1340379C Antimicrobial peptide, compositions containing same and uses thereof |
| 02/02/1999 | CA1340374C Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof |
| 02/02/1999 | CA1340371C Methods and products for facile microbial expression of dna sequences |
| 02/02/1999 | CA1340363C Mutant acidic fibroblast growth factor |
| 02/01/1999 | CA2238672A1 Seca |
| 02/01/1999 | CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999004266A2 Interactions of atm, atr or dna-pk with p53 |
| 01/28/1999 | WO1999004265A2 Cancer associated nucleic acids and polypeptides |
| 01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | WO1999004026A2 Lentiviral vectors |
| 01/28/1999 | WO1999004017A1 Recombinant staphylokinase and their high expression engineered strain |
| 01/28/1999 | WO1999004005A1 A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 01/28/1999 | WO1999004002A1 Human matrilin-3 |
| 01/28/1999 | WO1999004000A1 Adipocyte-specific protein homologs |
| 01/28/1999 | WO1999003999A1 Methods and compositions for inhibiting the proinflammatory response |
| 01/28/1999 | WO1999003998A1 Methods and compositions for tumor reduction |
| 01/28/1999 | WO1999003996A1 Modified dorsal tissue affecting factor and compositions |
| 01/28/1999 | WO1999003995A1 T-cell receptor beta-like protein |
| 01/28/1999 | WO1999003994A1 Suppressors of cytokine signaling socs16; related reagents |
| 01/28/1999 | WO1999003993A2 Suppressors of cytokine signaling; related reagents |
| 01/28/1999 | WO1999003992A1 Trail receptor |
| 01/28/1999 | WO1999003991A1 Proteins mediating switch recombination |
| 01/28/1999 | WO1999003990A1 64 human secreted proteins |
| 01/28/1999 | WO1999003989A1 Human atp-binding cassette transport protein |
| 01/28/1999 | WO1999003987A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | WO1999003982A1 Interleukin-20 |
| 01/28/1999 | WO1999003980A1 Agm-derived stroma cells |
| 01/28/1999 | WO1999003976A2 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 01/28/1999 | WO1999003890A1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 01/28/1999 | WO1999003889A1 Isolated dna encoding human calcium activated potassium channel |
| 01/28/1999 | WO1999003886A1 Tropoelastin derivatives |
| 01/28/1999 | WO1999003885A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 01/28/1999 | WO1999003883A1 Compositions and methods based upon the tuberous sclerosis-1 (tsc1) gene and gene product |
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003881A2 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 01/28/1999 | WO1999003880A1 Nociceptin analogues |
| 01/28/1999 | WO1999003879A1 Dolastatin 15 derivatives |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003508A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 01/28/1999 | WO1999003507A1 Telomere mimetic compounds and methods of use for same |
| 01/28/1999 | WO1999003506A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors |
| 01/28/1999 | WO1999003502A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 01/28/1999 | WO1999003499A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 01/28/1999 | WO1999003498A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY |
| 01/28/1999 | WO1999003497A1 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 01/28/1999 | WO1999003496A1 Factor ix antihemophilic factor with increased clotting activity |
| 01/28/1999 | WO1999003495A1 Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis |
| 01/28/1999 | WO1999003494A1 STRUCTURE OF THE ANKYRIN BINDING DOMAIN OF A ALPHA-Na,K-ATPase |
| 01/28/1999 | WO1999003493A1 Drugs containing as the active ingredient midkine or inhibitors thereof |
| 01/28/1999 | WO1999003492A1 Antiviral and antitumor agents |
| 01/28/1999 | WO1999003491A1 New use of nociceptin |
| 01/28/1999 | WO1999003490A1 Proteins and peptides for contraceptive vaccines and fertility diagnosis |
| 01/28/1999 | WO1999003489A2 Methods and compositions for regulating nuclear trafficking of proteins |
| 01/28/1999 | WO1999003488A2 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 01/28/1999 | WO1999003487A1 Delivery of agents and method for regeneration of periodontal tissues |
| 01/28/1999 | WO1999003486A1 Antacid and papain combination |
| 01/28/1999 | WO1999003484A1 Therapeutic hemoglobin composition having isotropically increased size |
| 01/28/1999 | WO1999003483A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/28/1999 | WO1999003454A1 Biodegradable macromers for the controlled release of biologically active substances |
| 01/28/1999 | WO1999003452A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 01/28/1999 | WO1999003352A1 Sublancin lantibiotic produced by bacillus subtilis 168 |
| 01/28/1999 | WO1999003328A1 TOXIN GENES FROM THE BACTERIA XENORHABDUS NEMATOPHILUS AND $i(PHOTORHABDUS LUMINESCENS) |
| 01/28/1999 | WO1998049333A3 Eukaryotic gene expression cassette and uses thereof |
| 01/28/1999 | WO1998049303A3 Compositions and methods for conferring tick immunity and preventing tick borne diseases |
| 01/28/1999 | WO1998046637A3 Herpes simplex virus us3 and icp4 as inhibitors of apoptosis |
| 01/28/1999 | WO1998046636A3 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 01/28/1999 | WO1998046632A3 Inhibitors for urokinase receptor |
| 01/28/1999 | WO1998038324A3 Chimeric cell-surface receptors that undergo antigen-induced association |
| 01/28/1999 | WO1998037200A3 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/28/1999 | WO1998027932A3 Cerebellum and embryo specific protein |
| 01/28/1999 | CA2521392A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/28/1999 | CA2298066A1 Methods and compositions for regulating nuclear trafficking of proteins |
| 01/28/1999 | CA2297103A1 Isolated dna encoding human calcium activated potassium channel |
| 01/28/1999 | CA2296815A1 64 human secreted proteins |
| 01/28/1999 | CA2296762A1 Interleukin-20 |
| 01/28/1999 | CA2296738A1 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 01/28/1999 | CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | CA2296700A1 Therapeutic hemoglobin composition having isotropically increased size |
| 01/28/1999 | CA2296666A1 T-cell receptor beta-like protein |
| 01/28/1999 | CA2296620A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 01/28/1999 | CA2296530A1 Adipocyte-specific protein homologs |
| 01/28/1999 | CA2296508A1 Structure of the ankyrin binding domain of a alpha-na,k-atpase |
| 01/28/1999 | CA2296459A1 Biodegradable macromers for the controlled release of biologically active substances |
| 01/28/1999 | CA2296447A1 Human atp-binding cassette transport protein |
| 01/28/1999 | CA2296419A1 A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 01/28/1999 | CA2296416A1 Assays therapeutic methods and means |